Skip to main content

Table 1 Patient demographics

From: Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in systemic lupus erythematosus

 

HD

SLE

n

19

40

Female

11 (58%)

37 (93%)

Agea

31 (20–59)

42 (22–76)

SLEDAIb

 

12(2–49)

Treatment naive

 

32 (80%)

Treatment

 PSL

 

7 (18%)

 HCQ

 

2 (5%)

 TAC

 

3 (7.5%)

 AZA

 

1 (2.5%)

  1. PSL Predonisone, HCQ Hydroxychloroquine, TAC Tacrolimus, AZA Azathioprine
  2. aMean and range
  3. bMean and range
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us